The most significant recent finding: a May 2026 Lancet randomized controlled trial (108 patients, 26 weeks) found semaglutide 2.4 mg reduced heavy drinking days by 41.1 percentage points versus 26.4 on placebo, a statistically significant 13.7-point difference
We evaluated outcomes in two populations: the total population with type 2 diabetes, and the secondary prevention population, which comprised everyone with type 2 diabetes and prior CVD
Furthermore, compared with control cells lacking SLCR-46.1::mCherry expression (Fig
Mortality rate in rats that received cysteamine enema, and then colon-colon anastomosis, and thereby, poor anastomosis healing along with prominent ulcerative colitis
Endoscopic weight loss procedures are performed through the mouth using a flexible endoscope
No se trata de la prdida de peso, se trata del mantenimiento